Fundraising Fox
NanoPath
Cambridge, US · Founded 2019 · Delaware corporation · 29 employees on LinkedIn · 9 known investors
Find your way into NanoPath
Sign up to find every way you can get introduced to NanoPath
- Your email: who you already know at NanoPath, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the NanoPath team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Nanopath is developing a molecular diagnostic platform for point-of-care disease diagnosis, with a focus on women's health. The company builds novel diagnostic technologies aimed at scalable, accessible testing.
Founders & leadership
NanoPath was founded in 2019 by Alison Burklund and Amogha Tadimety.
Board
Investors · 9
How we know: av.vc · Not right? Tell us
How we know: a partner's Signal profile · funding news · prnewswire.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Service Provider Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: SV Health Investors's portfolio page · prnewswire.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$15.3M disclosed across 2 rounds · 2022–2025
▶$5.3MraisedFeb 2025 · 5 investors · BiotechnologyRule 506(b)
- Alison BurklundExecutive Officer, Director
- Aaron SandoskiDirector
- Amogha TadimetyExecutive Officer, Director
- Jeff CroweDirector
- Offering amount
- $6M
- Amount sold
- $5.3M
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedAug 2022 · 10 investors · BiotechnologyRule 506(b)
- Jeffrey CroweDirector
- Alison BurklundExecutive Officer, Director
- Amogha TadimetyExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does NanoPath do?
- Nanopath is developing a molecular diagnostic platform for point-of-care disease diagnosis, with a focus on women's health. The company builds novel diagnostic technologies aimed at scalable, accessible testing.
- Who founded NanoPath?
- NanoPath was founded by Alison Burklund, Amogha Tadimety in 2019.
- Who are NanoPath's investors?
- NanoPath's investors include Alumni Ventures, Norwest Venture Partners, Service Provider Capital, SV Health Investors, Undeterred Capital, Gingerbread Capital, Green D Ventures, Medtech Convergence and 1 more.
- How much funding has NanoPath raised?
- NanoPath has disclosed $15.3M raised across 2 rounds.
- Where is NanoPath headquartered?
- NanoPath is headquartered in Cambridge, US.